Active Funding Opportunity Announcements (FOAs) for All NICHD
NICHD issues and participates in various FOAs to support research activities and training.
Investigator-Initiated (Unsolicited) Projects
To submit unsolicited or investigator-initiated applications, use the appropriate NIH Parent Announcement.
Active FOAs for NICHD
Please note: The following FOAs are sorted by date, from most recent to oldest. Select a table heading to change how to sort and display the FOAs.
| Announcement Number | Submissions Date(s) | Expiration Date | Activity Code(s) | Title |
|---|---|---|---|---|
| PA-18-670 | Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. | January 8, 2021 | F32 | Ruth L. Kirschstein National Research Service Award (NRSA) Individual Postdoctoral Fellowship (Parent F32) |
| PA-18-666 | Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. | January 8, 2021 | F31 | Ruth L. Kirschstein National Research Service Award (NRSA) Individual Predoctoral Fellowship to Promote Diversity in Health-Related Research (Parent F31) |
| PA-18-648 | Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. | January 8, 2021 | R13 | NIH Support for Conferences and Scientific Meetings (Parent R13 Clinical Trial Not Allowed) |
| PAR-18-649 | March 30, 2018, March 30, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. | March 31, 2019 | R03 | Human-Animal Interaction (HAI) Research (R03 - Clinical Trial Optional) |
| PAR-18-650 | March 30, 2018, March 30, 2019, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. | March 31, 2019 | R21 | Human-Animal Interaction (HAI) Research (R21 - Clinical Trial Optional) |
| PA-18-590 | A change of grantee organization request must be made before the anticipated start date at the new organization and preferably several months in advance. | January 26, 2021 | 777 | Change of Grantee Organization (Type 7 Parent Clinical Trial Optional) |
| PA-18-589 | A successor-in-interest request must be made before the anticipated start date at the new organization and preferably several months in advance. | January 26, 2021 | 666 | Successor-in-Interest (Type 6 Parent Clinical Trial Optional) |
| PA-18-592 | Due dates may vary by awarding IC. See Table of IC-Specific Information, Requirements and Staff Contacts for more details. | September 8, 2021 | 333 | Research Supplements to Promote Re-Entry into Biomedical and Behavioral Research Careers (Admin Supp - Clinical Trial Not Allowed ) |
| PA-18-586 | Due dates vary by awarding IC. See Table of IC-Specific Information, Requirements and Staff Contacts for more details. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. |
September 8, 2021 | 333 | Research Supplements to Promote Diversity in Health-Related Research (Admin Supp - Clinical Trial Not Allowed) |
| PA-18-591 | Due dates may vary by awarding IC. See the awarding IC web site for any applicable Application Due Dates. | January 26, 2021 | 333 | Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Parent Admin Supp - Clinical Trial Optional) |
| PA-18-574 | Standard dates apply by 5:00 PM local time of applicant organization. | April 6, 2019 | R43/R44 | PHS 2018-02 Omnibus Solicitation of the NIH, CDC, and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Not Allowed) |
| PA-18-575 | Standard dates apply , by 5:00 PM local time of applicant organization. | April 6, 2019 | R41/R42 | PHS 2018-02 Omnibus Solicitation of the NIH, CDC, and FDA for Small Business Technology Transfer Grant Applications (Parent STTR [R41/R42] Clinical Trial Not Allowed) |
| PA-18-576 | Standard dates apply, by 5:00 PM local time of applicant organization. | April 6, 2019 | R41/R42 | PHS 2018-02 Omnibus Solicitation of the NIH, CDC, and FDA for Small Business Technology Transfer Grant Applications (Parent STTR [R41/R42] Clinical Trial Required) |
| PA-18-573 | Standard dates apply by 5:00 PM local time of applicant organization. | April 6, 2019 | R43/R44 | PHS 2018-02 Omnibus Solicitation of the NIH, CDC, and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Required) |
| RFA-NS-18-022 | February 23, 2018, June 21, 2018, October 22, 2018, February 21, 2019, June 21, 2019, October 21, 2019, February 21, 2020, June 22, 2020, October 21, 2020, by 5:00 PM local time of applicant organization. | October 22, 2020 | U44 | BRAIN Initiative: Next-Generation Invasive Devices for Recording and Modulation in the Human Central Nervous System (U44 Clinical Trial Required) |
| RFA-NS-18-023 | February 23, 2018, June 21, 2018, October 22, 2018, February 21, 2019, June 21, 2019, October 21, 2019, February 21, 2020, June 22, 2020, October 21, 2020 , by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. | October 22, 2020 | UH3 | BRAIN Initiative: Clinical Studies to Advance Next-Generation Invasive Devices for Recording and Modulation in the Human Central Nervous System (UH3 - Clinical Trial Required) |
| RFA-NS-18-021 | February 23, 2018, June 21, 2018, October 22, 2018, February 21, 2019, June 21, 2019, October 21, 2019, February 21, 2020, June 22, 2020, October 21, 2020 , by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. | October 22, 2020 | UG3/UH3 | BRAIN Initiative: Next-Generation Invasive Devices for Recording and Modulation in the Human Central Nervous System (UG3/UH3 - Clinical Trial Required) |
| PAR-18-541 | February 7, 2018, August 9, 2018, February 9, 2019, August 9, 2019, February 11, 2020, by 5:00 PM local time of applicant organization. | May 8, 2020 | U44 | Blueprint Neurotherapeutics Network (BPN): Small Molecule Drug Discovery and Development for Disorders of the Nervous System (U44) - Clinical Trial Optional |
| PAR-18-546 | February 7, 2018, August 9, 2018, February 9, 2019, August 9, 2019, February 11, 2020, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. | May 8, 2020 | UG3/UH3 | Blueprint Neurotherapeutics Network (BPN): Small Molecule Drug Discovery and Development of Disorders of the Nervous System (UG3/UH3) - Clinical Trial Optional |
| PAR-18-511 | Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. |
January 8, 2021 | R01 | Discovery of Molecular Targets for Pregnancy-Related/Induced Diseases and Development of Therapeutics to Prevent/Treat These Diseases (R01 - Clinical Trial Optional) |
BACK TO TOP